Clinical benefits of concomitant surgical ablation for atrial fibrillation in patients undergoing mitral valve surgery

Kim, Hee Jung; Han, Kyungdo; Kim, Wan Kee; Cho, Yang Hyun; Lee, Seung–Hyun; Je, Hyung Gon

doi:10.1016/j.hrthm.2022.09.014

Cited by 5 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Observational data strongly support the wide adoption of the most extensive AF ablation procedure (Biatrial Cox maze intervention) during concomitant cardiac surgery [52][53][54][55][56][57][58][59]. The multilevel benefits of such an intervention in terms of restoration of the sinus rhythm; control of LAA; and potentially secondary benefits (improved hemodynamics, reduced thromboembolic events, improved quality of life, restoration of left ventricular dysfunction, and potentially increased survival) make this procedure a Class I recommendation in the STS guidelines during concomitant cardiac surgery [60].…”

Section: Special Considerations In Surgical Laa Managementmentioning

confidence: 89%

Non-Pharmacological Stroke Prevention in Atrial Fibrillation

Anduaga,

Affronti,

Cepas-Guillén

et al. 2023

JCM

View full text Add to dashboard Cite

Atrial fibrillation (AF) is the most common arrhythmia worldwide. It is associated with increased mortality and morbidity, especially due to the increased risk of ischemic stroke and systemic embolism in these patients. For this reason, thromboembolism prevention is the cornerstone of managing AF, and oral anticoagulation is nowadays the first-line treatment. However, since most thrombi form in the left atrial appendage and anticoagulant therapy may have side effects and be contraindicated in some patients, surgical and percutaneous left atrial appendage occlusion (LAAO) have emerged as a non-pharmacological alternative. This review summarizes all existing evidence on surgical and percutaneous LAAO.

show abstract

Section: Special Considerations In Surgical Laa Managementmentioning

confidence: 89%

Non-Pharmacological Stroke Prevention in Atrial Fibrillation

Anduaga,

Affronti,

Cepas-Guillén

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

“…A randomized trial that was performed on patients with MV disease of various etiologies also did not show a survival benefit resulting from surgical AF ablation [ 15 ]. However, 2 studies that were performed on a Korean national cohort consistently showed that concomitant surgical ablation (SA) significantly decreased the long-term risk of mortality and thromboembolic events in patients undergoing MV surgery [ 16 , 17 ]. Although these studies were also limited by the fact that the etiology of MV disease was not specified, a significant proportion of RHD patients was expected to be included in these studies because of the high prevalence of RHD in Korea.…”

Section: Atrial Fibrillation Surgery In Rheumatic Mitral Valve Diseasementioning

confidence: 99%